Session 7: Genome and epigenome editing: On the road towards the clinic

09:00-09:15  

Claudio Mussolino, University of Freiburg; Julian Grünewald, Technische Universität München

Genome and epigenome editing – current status in a nutshell

INV20    09:15-09:45  

Toni Cathomen, University of Freiburg  ⓘ

On- and off-target effects of gene editing tools in human stem cells

INV21     09:45-10:15  

Virgis Siksnys, Vilnius University  ⓘ

Novel CRISPR-Cas nucleases as potential genome editing tools?

INV22    10:15-10:45  

Frank Buchholz, TU Dresden  ⓘ

Genome Editing with Designer-Recombinases 

OR10    10:45-11:00  

Viviane Dettmer-Monaco, Medical Center- University of Freiburg

Gene editing of hematopoietic stem cells restores the cytotoxic T cell response in a murine model of familial hemophagocytic lymphohistiocytosis type 3

ABSTRACT >

OR11    11:00-11:15  

Adrian Schwarzer, Hannover Medical School

A four-color AAV6 system for efficient biallelic homology-directed genome editing (HDR) without AAV vector integration into CRISPR-Cas9 induced double-strand breaks

ABSTRACT >